Personalized medicine and pharmacogenetic biomarkers: progress in molecular oncology testingFrank S Ong, Wayne W. Grody, Kingshuk Das et al.|Expert Review of Molecular Diagnostics|2012Cited by 96
A diagnostic ceiling for exome sequencing in cerebellar ataxia and related neurological disordersKathie J. Ngo, Brent L. Fogel, Mamdouh Aker et al.|Human Mutation|2019Cited by 89
A Recurrent De Novo Variant in NACC1 Causes a Syndrome Characterized by Infantile Epilepsy, Cataracts, and Profound Developmental DelayKelly Schoch, Sureni V. Mullegama, Linyan Meng et al.|The American Journal of Human Genetics|2017Cited by 51
Clinical Utility of Pharmacogenetic Biomarkers in Cardiovascular Therapeutics: a Challenge for Clinical ImplementationFrank S Ong, Kingshuk Das, Joshua L. Deignan et al.|Pharmacogenomics|2012Cited by 31